Cerner partners with Holon to help automate clinical decision-making and identify gaps in care

EHR
Holon’s CollaborNet platform observes providers' activity and displays relevant information linked to patients—alongside their digital charts—without interrupting their work. (Rostislav_Sedlacek/Getty Images)

Health IT provider Cerner Corporation has tapped Holon Solutions to help it deliver contextually relevant patient information through its cloud-based population health platform.

Cerner’s HealtheIntent offering amasses data from multiple sources—including different electronic health record systems as well as insurance claims and pharmacy records—to help provide a longitudinal record of a patient’s care and identify gaps at both the personal level and in wider populations. 

Holon, meanwhile, works to quickly provide clinicians with a person’s relevant healthcare information during the patient visit, including data from sources outside their immediate electronic record. The company’s software also aims to efficiently fill the gaps in a person’s care history by prompting the provider while the patient is still in the room.

Event

Join the world's top medtech executives virtually for the leading event in medtech — The Virtual MedTech Conference by AdvaMed

Expect the same high-quality education, world-class speakers and valuable business development in a virtual format. Experience more of the conference with on demand content and partnering, as well as livestreamed sessions.

“Holon’s advanced capabilities will help us automatically bring providers relevant information, insights and critical health data to help them guide patient care in a timely manner,” said Ray Herschman, Cerner’s vice president and general manager of its health network and risk solutions. The financial terms of the collaboration were not disclosed.

RELATED: Cerner's expanding partnership with Amazon will be key to its 2020 growth strategy

Holon’s CollaborNet platform also observes providers' activity and displays relevant information linked to patients, alongside their digital charts, without interrupting their work.

“Delivering critical knowledge at the point of need is the foundation of Holon’s mission in the market,” said Holon CEO Jon Zimmerman. “We are thrilled to be collaborating with Cerner to ensure the valuable information generated reaches providers when and where they need it—with no effort on the provider’s part—as a huge step toward better quality care, provider experience, business performance, and improving outcomes.”

Suggested Articles

The deal gives Roche full rights to a pipeline of oral NLRP3 inhibitors led by two clinical-phase treatments for Parkinson’s and other diseases.

J&J's EGFR-fighting combo stopped tumor growth in 60% of patients whose lung cancer got worse after taking AstraZeneca's Tagrisso.

Amgen's KRAS inhibitor curbed tumor growth in 88% of patients with non-small cell lung cancer, shrinking tumors in one-third of them.